C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/06 (2006.01) A61K 31/445 (2006.01)
Patent
CA 2506568
2-[(4-Benzyl)-1-piperidinyl)-methyl]benzimidazole-5-ol derivatives are NMDA NR2B receptor antagonists useful in the treatment of pain and other NMDA mediated diseases.
L'invention concerne l'utilisation de dérivés de 2-[(4-Benzyl)-1-pipéridinyl)-méthyl]benzimidazole-5-ol, des antagonistes des récepteurs du NMDA NR2B, dans le traitement de la douleur et d'autres maladies induites par le NMDA.
Claremon David A.
Liverton Nigel J.
Mccauley John A.
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
2-[(4-benzyl)-1-piperidinyl)methyl]benzimidazole-5-ol... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-[(4-benzyl)-1-piperidinyl)methyl]benzimidazole-5-ol..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-[(4-benzyl)-1-piperidinyl)methyl]benzimidazole-5-ol... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1605938